SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TFF Pharmaceuticals, Inc. - TFFPNewsfile Corp • 11/19/22
TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and WarrantsGlobeNewsWire • 11/18/22
TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock and WarrantsGlobeNewsWire • 11/17/22
TFF Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/14/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TFF Pharmaceuticals, Inc. - TFFPPRNewsWire • 11/14/22
TFF Pharmaceuticals to Hold Third Quarter 2022 Financial and Business Results Conference Call on November 14, 2022GlobeNewsWire • 11/07/22
TFF Pharmaceuticals Announces Collaboration with Aptar Pharma to Explore and Develop Intranasal Delivery of Dry Powder Vaccines and Dry Powder TherapeuticsGlobeNewsWire • 11/03/22
TFF Pharmaceuticals Announces Second Patient Successfully Treated with Voriconazole Inhalation Powder Through Compassionate Use ProgramGlobeNewsWire • 11/01/22
TFF Pharmaceuticals Announces Program Updates for Voriconazole Inhaled Powder and Tacrolimus Inhaled Powder Clinical ProgramsGlobeNewsWire • 11/01/22
TFF Pharmaceuticals Announces Presentation of Data Featuring Applications of Thin Film Freezing Technology at AAPS PharmSci 360 MeetingGlobeNewsWire • 10/11/22
TFF Pharmaceuticals to Participate in the Roth Inaugural Healthcare Opportunities ConferenceGlobeNewsWire • 09/26/22
TFF Pharmaceuticals Announces Acceptance of Multiple Abstracts Featuring Applications of Thin Film Freezing Technology at the Upcoming AAPS PharmSci 360 MeetingGlobeNewsWire • 09/22/22
TFF Pharmaceuticals Announces Presentation of Patient Data with Voriconazole Inhalation Powder (TFF VORI) at the 15th International Congress on Lung TransplantationGlobeNewsWire • 09/08/22
TFF Pharmaceuticals to Participate at The H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/06/22
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22
TFF Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/11/22
TFF Pharmaceuticals to Hold Second Quarter 2022 Financial and Business Results Conference Call on August 11, 2022GlobeNewsWire • 08/02/22
TFF Pharmaceuticals to Participate at The JMP Securities Life Sciences ConferenceGlobeNewsWire • 06/09/22